HIVE Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own HIVE shares is 128, representing 23.28% of the company's common stock.

CAPTRUST FINANCIAL ADVISORS, in the last quarter, reduced its stake in HIVE by -100% restricting it's holding to 0 shares of worth nearly -. RONALD BLUE TRUST, INC. also lessened -100% of the HIVE shares from its portfolio, reducing its holding to 0 shares of worth -. WELLINGTON MANAGEMENT GROUP LLP also shunned HIVE shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, RONALD BLUE TRUST, INC. increased its stake in HIVE by 100% in the last quarter. The institutional holder raised its holding to 500 shares having worth more than $1.00K. N/A also added N/A more shares of HIVE to its portfolio, raising its holding to - shares of worth -. N/A also increased its HIVE shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in HIVE is DEBENHAM STEPHEN , VP, Gen. Counsel & Secretary at the company. Additionally, HIVE stock is highly held by SVP, CFO & COO Ritchie John and director SCHAEPE CHRISTOPHER J among others.

Company executives, directors, and other insiders own 0.4% percent of HIVE Blockchain Technologies Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which HIVE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include DEBENHAM STEPHEN and SCHAEPE CHRISTOPHER J.

There have been 0 transaction(s) during the past 6-months in which HIVE Blockchain Technologies Ltd. insiders have bought stock, totalling 0 shares

Around 0 HIVE Blockchain Technologies Ltd. shares are held by insiders, which represents about 0.4% of HIVE stock.

HIVE VP, Gen. Counsel & Secretary, DEBENHAM STEPHEN holds the largest portfolio of the company's shares. HIVE shares owned by DEBENHAM total nearly 278.41 thousand.

CAPTRUST FINANCIAL ADVISORS is the largest institutional owner in HIVE which holds 0 shares worth - or 0% of the total HIVE shares outstanding followed by RONALD BLUE TRUST, INC. with ownership of 0 shares representing 0% of the HIVE ownership. WELLINGTON MANAGEMENT GROUP LLP is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the HIVE is concerned, it is a stock which is optionable.

Number of HIVE shares short is 7.89M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 92.54M shares of HIVE are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, HIVE has 100.24M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for HIVE is null.